Introduction to Nephrotic Syndrome

Definition and Pathophysiology of Nephrotic Syndrome What Is Nephrotic Syndrome? Nephrotic syndrome is a kidney disorder characterized by abnormal leakiness of the glomeruli (the filtering units of the kidney). This leakiness allows large plasma proteins, particularly albumin, to escape into the urine in massive amounts. Understanding the cascade of events that follows is essential to grasping this condition. The Mechanism: How Protein Loss Causes Edema The development of nephrotic syndrome involves a specific chain of pathophysiologic events that you should understand clearly. Step 1: Massive Protein Loss in Urine In healthy kidneys, the glomerular filtration barrier normally prevents large proteins like albumin from passing into the urine. In nephrotic syndrome, this barrier malfunctions, allowing protein excretion exceeding $3.5\ \text{g}$ per 24 hours. For context, healthy individuals typically lose less than $0.15\ \text{g}$ of protein daily, so this represents a dramatic increase. Step 2: Decreased Serum Albumin As albumin is continuously lost in the urine, the liver cannot synthesize replacement albumin quickly enough, causing serum albumin concentration to drop below $3\ \text{g/dL}$ (normal is $3.5$–$5.0\ \text{g/dL}$). This is a defining diagnostic feature. Step 3: Fluid Shifts and Edema Formation Here's the crucial mechanism that often causes confusion: albumin is osmotically active, meaning it attracts water and keeps it in the bloodstream. When serum albumin falls, the oncotic pressure (the "pulling" force that holds fluid inside blood vessels) decreases. Without adequate oncotic pressure to counteract normal hydrostatic pressure, fluid shifts from the vascular compartment into the tissues, causing visible swelling or edema. This can be severe, affecting the face, legs, and abdomen. Step 4: The Liver's Compensatory Response The liver senses the low albumin and responds by synthesizing more lipoproteins—including cholesterol and triglycerides. This leads to hyperlipidemia (elevated blood lipids), which is another characteristic finding in nephrotic syndrome. This is an important complication because it increases cardiovascular risk. Diagnostic Criteria and Laboratory Findings Diagnostic Features Nephrotic syndrome is diagnosed through laboratory findings that demonstrate both massive protein loss and its metabolic consequences. Massive Proteinuria The hallmark finding is protein excretion greater than $3.5\ \text{g}$ per 24 hours. This can be measured either by collecting a 24-hour urine sample or more conveniently by calculating the spot urine protein-to-creatinine ratio (which should exceed $0.3\ \text{g/g}$). The spot method is increasingly preferred because it's easier for patients and clinically reliable. Low Serum Albumin Serum albumin concentration falls below $3\ \text{g/dL}$ due to ongoing urinary losses. Additional Laboratory Abnormalities Hyperlipidemia: Elevated total cholesterol and triglycerides result from increased hepatic synthesis Coagulation abnormalities: Nephrotic syndrome increases the risk of thromboembolism (blood clots), so coagulation studies and clotting factors are assessed Kidney function: Serum creatinine and electrolyte levels evaluate overall glomerular filtration rate and electrolyte balance Etiology: Primary and Secondary Causes Primary (Idiopathic) Causes Primary nephrotic syndrome arises from direct glomerular disease in the absence of systemic illness. Three major histologic patterns account for most cases: Minimal-Change Disease This is the most common cause of nephrotic syndrome in children. Despite causing massive proteinuria, glomeruli appear normal under light microscopy—hence the name "minimal-change." Electron microscopy reveals foot process effacement (flattening of the podocyte architecture). This disease typically responds well to corticosteroid therapy. Focal Segmental Glomerulosclerosis (FSGS) This pattern shows sclerosis (scarring and fibrosis) affecting only portions of glomeruli ("focal") and only some glomeruli ("segmental"). It's more common in adolescents and adults and is associated with higher risk of progression to chronic kidney disease. FSGS may respond partially to steroids, but often requires additional immunosuppressive therapy. Membranous Nephropathy This disease is characterized by thickening of the glomerular basement membrane due to immune complex deposition. It's the most common cause of nephrotic syndrome in adults and has significant association with autoimmune diseases, infections (especially hepatitis B and C), and certain medications. Prognosis is variable—some patients remit spontaneously, while others progress to kidney failure. Secondary Causes Secondary nephrotic syndrome develops as a manifestation of systemic disease or external exposures: Diabetes mellitus: Diabetic nephropathy is the most common cause of nephrotic syndrome worldwide, resulting from glomerular injury caused by chronic hyperglycemia and hypertension Systemic lupus erythematosus (SLE): Immune complexes deposit in glomeruli, causing various patterns of glomerulonephritis Chronic infections: Hepatitis B virus, hepatitis C virus, and other infections can trigger immune complex–mediated glomerulonephritis Medications: Certain drugs (such as NSAIDs, bisphosphonates, and some biologics) can induce nephrotic syndrome Malignancies: Solid tumors (lung, stomach, colon, breast) are associated with secondary nephrotic syndrome, often through immune complex deposition Diagnostic Evaluation When Is Kidney Biopsy Indicated? Because nephrotic syndrome can result from multiple different diseases with varying prognoses and treatments, identifying the specific cause is crucial. A kidney biopsy is performed when: The underlying cause is unclear from clinical history and laboratory findings Primary disease is suspected but the specific pattern (minimal-change, FSGS, membranous) needs confirmation Secondary causes haven't been adequately identified or ruled out Biopsy allows direct histologic examination to identify the glomerular disease pattern, which guides treatment decisions. For example, minimal-change disease warrants immediate corticosteroid therapy, while membranous nephropathy management may differ. Management Strategies Nephrotic syndrome management addresses multiple goals simultaneously: reducing protein loss, controlling edema, preventing thromboembolism, and preserving long-term kidney function. Immunosuppressive Therapy Corticosteroids Corticosteroids, particularly oral prednisone, are first-line therapy for primary forms of nephrotic syndrome. These drugs suppress the immune system and reduce glomerular inflammation. In minimal-change disease, corticosteroids are highly effective, often producing complete remission of proteinuria within 4–8 weeks. Response is less predictable in other forms like FSGS or membranous nephropathy. Goal: Achieve complete or partial remission, defined as reduction of proteinuria to $<0.3\ \text{g/day}$ or normalization of serum albumin. Blood-Pressure Control and Proteinuria Reduction Angiotensin-Converting Enzyme (ACE) Inhibitors These drugs lower intraglomerular pressure by dilating the efferent arteriole, reducing the hydraulic forces driving proteinuria. They modestly reduce protein excretion even beyond their blood pressure-lowering effects and provide long-term kidney protection. Examples include lisinopril and enalapril. Angiotensin II Receptor Blockers (ARBs) These agents provide similar benefits by blocking angiotensin II receptors, producing vasodilation of the efferent arteriole. They're used when ACE inhibitors aren't tolerated. Examples include losartan and valsartan. Both ACE inhibitors and ARBs should generally not be used together due to additive risk of hyperkalemia and renal dysfunction. Edema Management Diuretics Loop diuretics (such as furosemide) or thiazide diuretics are prescribed to promote sodium and water excretion, reducing fluid overload and edema. The choice and dose depend on the severity of edema and kidney function. Dietary Sodium Restriction A low-sodium diet (typically $<2\ \text{g}$ daily) reduces fluid retention and enhances diuretic effectiveness. This is often the first step in edema management. Albumin Infusions In cases of severe hypoalbuminemia ($<1.5\ \text{g/dL}$) with refractory edema unresponsive to diuretics and dietary measures, intravenous albumin infusions may provide temporary oncotic support. However, this is expensive and provides only temporary benefit. Lipid Management Statins and Other Lipid-Lowering Agents Statins (such as atorvastatin or simvastatin) are prescribed to lower cholesterol and reduce cardiovascular risk. Nephrotic syndrome substantially increases atherosclerotic cardiovascular disease risk, making lipid control important for long-term health. Thromboembolism Prevention Anticoagulation Therapy Nephrotic syndrome increases clotting risk through multiple mechanisms: loss of anticoagulant proteins (antithrombin, protein C) in the urine, increased synthesis of procoagulant factors by the liver, and blood stasis from edema. Anticoagulation with warfarin or other agents may be indicated, particularly in membranous nephropathy or in patients with documented thrombosis. Long-Term Monitoring Ongoing management includes: Regular assessment of kidney function (serum creatinine, estimated glomerular filtration rate) Monitoring of proteinuria levels (to assess treatment response) Surveillance for medication side effects, especially corticosteroid-related complications (infection, osteoporosis, metabolic effects) Cardiovascular risk factor management Key Summary for Examination Understanding nephrotic syndrome requires mastering its pathophysiology, recognition of diagnostic features, knowledge of common etiologic causes, and familiarity with the multimodal treatment approach: Pathophysiology: Leaky glomeruli → protein loss → hypoalbuminemia → oncotic pressure loss → edema; compensatory hyperlipidemia Diagnosis: Proteinuria $>3.5\ \text{g/day}$, serum albumin $<3\ \text{g/dL}$, elevated lipids, elevated coagulation risk Etiology: Primary diseases (minimal-change, FSGS, membranous nephropathy) versus secondary causes (diabetes, SLE, infections, medications, malignancies) Management: Corticosteroids (when appropriate), ACE-I/ARBs, diuretics, dietary sodium restriction, statins, and anticoagulation as indicated